• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫利达嗪及其代谢产物在死后获取的人体组织和体液中的分布。

Distribution of thioridazine and its metabolites in human tissues and fluids obtained postmortem.

作者信息

Dinovo E C, Bost R O, Sunshine I, Gottschalk L A

出版信息

Clin Chem. 1978 Oct;24(10):1828-30.

PMID:699294
Abstract

Thioridazine and metabolites were measured in brain, liver, and kidney specimens, obtained postmortem from two subjects whose deaths were related to acute intoxication with thioridazine, by gas-liquid chromatography. Although the absolute concentration measured for thioridazine and metabolites differed in the two cases, the metabolic pattern for each tissue, expressed in terms of the percentage of total drug in each tissue, was quite similar. The brain, liver, and kidney metabolic patterns, however, are in sharp contrast to the plasma metabolite patterns observed for subjects on a therapeutic regimen of thioridazine. As this example demonstrates, postmortem specimens are a valuable (but seldom used) source of human pharmacological data.

摘要

通过气液色谱法对两名因硫利达嗪急性中毒死亡的受试者死后获取的脑、肝和肾标本中的硫利达嗪及其代谢产物进行了测定。尽管两例中测得的硫利达嗪及其代谢产物的绝对浓度有所不同,但以各组织中总药物百分比表示的每个组织的代谢模式却非常相似。然而,脑、肝和肾的代谢模式与接受硫利达嗪治疗方案的受试者所观察到的血浆代谢产物模式形成鲜明对比。正如这个例子所示,死后标本是人体药理学数据的宝贵(但很少使用)来源。

相似文献

1
Distribution of thioridazine and its metabolites in human tissues and fluids obtained postmortem.硫利达嗪及其代谢产物在死后获取的人体组织和体液中的分布。
Clin Chem. 1978 Oct;24(10):1828-30.
2
High-pressure liquid chromatographic determination of thioridazine and its major metabolites in biological tissues and fluids.高效液相色谱法测定生物组织和体液中硫利达嗪及其主要代谢产物
J Chromatogr Sci. 1985 Dec;23(12):541-5. doi: 10.1093/chromsci/23.12.541.
3
Thioridazine-fluoxetine interaction at the level of the distribution process in vivo.硫利达嗪与氟西汀在体内分布过程水平上的相互作用。
Pol J Pharmacol. 2002 Nov-Dec;54(6):647-54.
4
Thioridazine and its metabolites in post mortem blood, including two stereoisomeric ring sulfoxides.硫利达嗪及其在死后血液中的代谢产物,包括两种立体异构的环亚砜。
J Anal Toxicol. 1982 Sep-Oct;6(5):250-2. doi: 10.1093/jat/6.5.250.
5
Postmortem redistribution of two antipsychotic drugs, haloperidol and thioridazine, in the rat.大鼠体内两种抗精神病药物氟哌啶醇和硫利达嗪的死后再分布
J Anal Toxicol. 2006 Sep;30(7):419-25. doi: 10.1093/jat/30.7.419.
6
Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.卡马西平长期联合给药后吩噻嗪类抗精神病药的药代动力学
Pol J Pharmacol. 1998 Nov-Dec;50(6):431-42.
7
The disposition and elimination of stereoisomeric pairs of thioridazine 5-sulfoxide in the rat.
Eur J Drug Metab Pharmacokinet. 1985 Oct-Dec;10(4):333-41. doi: 10.1007/BF03189762.
8
Gas-liquid chromotographic determination of perazine, thioridazine and thioridazine metabolites in human plasma.
J Chromatogr. 1976 May 12;120(1):123-8. doi: 10.1016/s0021-9673(01)99003-x.
9
Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.硫利达嗪及其代谢产物在大鼠急性和慢性治疗后血浆和脑中的药代动力学。
Pol J Pharmacol. 1997 Nov-Dec;49(6):439-52.
10
About a non-fatal massive intoxication with sustained-release thioridazine. Clinical and therapeutic problems.关于一例硫利达嗪缓释制剂非致命性大量中毒。临床及治疗问题。
Acta Pharmacol Toxicol (Copenh). 1977;41 Suppl 2:153-62.

引用本文的文献

1
In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.新型非典型抗精神病药物阿塞那平对人细胞色素 P450 酶的体外抑制作用:预测可能的药物-药物相互作用。
Pharmacol Rep. 2020 Jun;72(3):612-621. doi: 10.1007/s43440-020-00089-z. Epub 2020 Mar 26.
2
Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases.硫利达嗪作为鸟分枝杆菌复合群疾病的化疗药物
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4652-8. doi: 10.1128/AAC.02985-15. Print 2016 Aug.
3
Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.
硫利达嗪的药代动力学-药效学参数在结核病治疗期间“摆动”:同类药物短疗程治愈性单药治疗的理论基础。
Antimicrob Agents Chemother. 2013 Dec;57(12):5870-7. doi: 10.1128/AAC.00829-13. Epub 2013 Sep 16.
4
Comparative cytochrome p450 in vitro inhibition by atypical antipsychotic drugs.非典型抗精神病药物对细胞色素P450的体外抑制作用比较
ISRN Pharmacol. 2013;2013:792456. doi: 10.1155/2013/792456. Epub 2013 Feb 13.
5
Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol.氟哌啶醇代谢物对CYP2D6的强效抑制作用:还原型氟哌啶醇的立体选择性抑制
Br J Clin Pharmacol. 2001 Jan;51(1):45-52. doi: 10.1046/j.1365-2125.2001.01313.x.
6
HPLC with electrochemical detection to measure chlorpromazine, thioridazine and metabolites in human brain.
Psychopharmacology (Berl). 1986;90(3):316-21. doi: 10.1007/BF00179183.